Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023862
Filing Date
2020-05-11
Accepted
2020-05-11 08:01:49
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20200331.htm 10-Q 1853700
2 EX-31.1 alrn-ex311_9.htm EX-31.1 16315
3 EX-31.2 alrn-ex312_7.htm EX-31.2 16191
4 EX-32.1 alrn-ex321_6.htm EX-32.1 7915
5 EX-32.2 alrn-ex322_8.htm EX-32.2 7028
  Complete submission text file 0001564590-20-023862.txt   5899926

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20200331.xml EX-101.INS 1180432
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20200331.xsd EX-101.SCH 40789
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20200331_cal.xml EX-101.CAL 36326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20200331_def.xml EX-101.DEF 129542
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20200331_lab.xml EX-101.LAB 359261
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20200331_pre.xml EX-101.PRE 266914
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 20862676
SIC: 2834 Pharmaceutical Preparations